Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
A guess at news then
By mid march
LFT larger evaluation news
BAMS final performance results
By second half of March
BAMS comes to market beyond current research use
LFD starts coming on sale by Mologic and Avacta CE and ISO
News of contracts
News of more manufacturers
By first half of April
LFD starts being manufactured across manufacturing partners
More contract news.
Feel like LFT manufacturing scale increase news would be next up
The price ticked up sharply just before close and thinking about how this ship leaks, smacked a little more onto my spread bet - and I was really struggling to buy, so maybe...
Probably impressive if AS explained it trek..... Yawn
Thanks Luke et al,
https://youtu.be/Mr8glaM4ruM
But of course the hope is that BAMS news comes early...
There was also this Rich.. think it will be a couple of weeks
This evaluation is expected to continue for another two or three weeks and the Group is establishing outsourced manufacturing capacity for the BAMS tests in collaboration with Adeptrix so that it is in a position to formally validate the diagnostic product as soon as possible. Avacta is also in discussions with a large commercial partner to provide a route to market for the BAMS assay.
From the update: "This evaluation is expected to continue for another two or three weeks and the Group is establishing outsourced manufacturing capacity for the BAMS tests in collaboration with Adeptrix so that it is in a position to formally validate the diagnostic product as soon as possible. Avacta is also in discussions with a large commercial partner to provide a route to market for the BAMS assay."
This is pretty impressive....
“ACROBiosystems has launched matched antibody pairs that are specifically designed and screened for antigen detection kit development, which are suitable for different diagnostic assays, such as chemiluminescent immunoassay, ELISA, gold immunochromatography assay, etc. The sensitivity of the sandwich ELISA can be as low as 12 pg/mL in the verification study using recombinant antigens. In addition, the antibody pairs have been verified using inactivated virus samples. The titer, which was determined using our LFA assay, is as low as 5 TCID50.
Facing increasingly complex mutations, scientists are concerned whether the new mutants could be detected by rapid antigen tests. ACROBiosystems successfully verified that our high-sensitive antibody pair (Cat. No. S1N-M12A1/S1N-M13A1) can detect the latest SARS-CoV-2 variants.”
https://www.acrobiosystems.com/A1126-Antigens--Antibodies-for-Diagnostic-Kit-Development.html?utm_source=newsmedical&utm_medium=newsletter&utm_campaign=sars-cov-2&utm_content=antibodypair&utm_term=newsmedical
Trek
Luke, it said:
BAMS™ SARS-CoV-2 Antigen Test clinical evaluation underway at a UK NHS hospital site. Initial performance data are encouraging and work is continuing to refine the assay protocol for use in the clinical workflow on hospital-based MALDI-TOF instruments. On 28 January 2021 we entered a collaboration agreement with Bruker Corporation to evaluate the clinical utility and commercial potential of this test.
Think this should be about there.
Onwards Avacta.
Didn’t the trading update say Bams performance data due in 2/3 weeks?
I have it on good authority that there will be a part two of the interview at which BAMS and other issues will be addressed
Don't recall anything about BAMS today.
Can't believe that the well researched interviewer hasn't heard about and clearly Alistair knows all about it.
Timescale wise, if CE marking by Mologic is anything to go by, the timing must be close.
Onwards Avacta.